Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 2966-2976, May 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tennenbaum, T.
Right arrow Articles by De Luca, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tennenbaum, T.
Right arrow Articles by De Luca, L. M.

Extracellular Matrix Receptors and Mouse Skin Carcinogenesis: Altered Expression Linked to Appearance of Early Markers of Tumor Progression1

Tamar Tennenbaum2, Stuart H. Yuspa, Atul Grover, Vincent Castronovo, Mark E. Sobel, Yoshihiko Yamada and Luigi M. De Luca

Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Cancer Etiology [T. T., S. H. Y., A. G., L. M. D.] and Laboratory of Tumor Pathology [V. C., M. E. S.J, National Cancer Institute, and Laboratory of Developmental Biology, National Institute of Dental Research [Y. Y.], National Institutes of Health, Bethesda, Maryland 20892

Interaction of cells with the basement membrane is important for cell proliferation and differentiation. Disruption of the basement membrane is an early event during progression of benign tumors to cancer. Using the techniques of immunohistochemistry and immunofluorescence, we show that cell-matrix interactions via the cell surface integrin receptors {alpha}3ß1, {alpha}5ß1, {alpha}6ß4, the Mr 67,000 laminin receptor (67LR) lamininbinding protein, and the secreted matrix protein laminin are strictly regulated during differentiation of mouse epidermis. While {alpha}6ß4 and {alpha}5ß1 are polarized to the basal surface of basal cells in contact with the basement membrane, {alpha}3ß1 and the non-integrin 67LR are primarily detected in the cell periphery of suprabasal cells, where cell to cell contacts are found. Sequential changes in expression of matrix receptors occur following multistage carcinogenesis of mouse skin. In an analysis of benign and malignant skin tumors induced by chemical carcinogens or oncogene transduction, we found that {alpha}3ß1 and {alpha}5ß1 as well as the non-integrin 67LR are sequentially down-regulated in the progression from benign to malignant, while {alpha}6ß4 is the predominant receptor expressed in the carcinomas. Tumor expression of {alpha}6ß4 is not polarized and is dissociated from its colocalized normal partner bullous pemphigoid antigen, which remains restricted to the basement membrane. The changes in matrix receptors are linked to appearance of keratin 13 in suprabasal regions, but always in {alpha}6ß4 negative cells. The predominance of {alpha}6ß4 in the proliferating cells during progression is associated with decreased expression of keratin 13 in carcinomas. These results suggest that matrix interactions with its receptors are important determinants of ordered differentiation in normal skin and show characteristic alterations during carcinogenesis that parallel changes in differentiation of the tumors.

1 This work was supported by a grant from Johnson & Johnson, Consumer Products corporation. T. T. is the recipient of a fellowship from the Israel Cancer Research Fund and the European Organization for Research and Treatment of Cancer.

2 To whom requests for reprints should be addressed, at National Cancer Institute, Laboratory of Cellular Carcinogenesis and Tumor Promotion, Building 37, Room 3B25, Bethesda, MD 20892.

Received 12/ 4/91. Accepted 3/10/92.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. Taverna and R. O. Hynes
Reduced Blood Vessel Formation and Tumor Growth in {{alpha}}5-Integrin-negative Teratocarcinomas and Embryoid Bodies
Cancer Res., July 1, 2001; 61(13): 5255 - 5261.
[Abstract] [Full Text] [PDF]


Home page
Genome Res.Home page
I. Marenholz, M. Zirra, D. F. Fischer, C. Backendorf, A. Ziegler, and D. Mischke
Identification of Human Epidermal Differentiation Complex (EDC)-Encoded Genes by Subtractive Hybridization of Entire YACs to a Gridded Keratinocyte cDNA Library
Genome Res., March 1, 2001; 11(3): 341 - 355.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
C. M. Witkowski, G.T. Bowden, R. B. Nagle, and A. E. Cress
Altered surface expression and increased turnover of the {alpha}6{beta}4 integrin in an undifferentiated carcinoma
Carcinogenesis, February 1, 2000; 21(2): 325 - 330.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Adachi, T. Taki, M. Higashiyama, N. Kohno, H. Inufusa, and M. Miyake
Significance of Integrin {{alpha}}5 Gene Expression as a Prognostic Factor in Node-negative Non-Small Cell Lung Cancer
Clin. Cancer Res., January 1, 2000; 6(1): 96 - 101.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
C. M. DiPersio, K. M. Hodivala-Dilke, R. Jaenisch, J. A. Kreidberg, and R. O. Hynes
alpha 3beta 1 Integrin Is Required for Normal Development of the Epidermal Basement Membrane
J. Cell Biol., May 5, 1997; 137(3): 729 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. Giancotti
Signal transduction by the alpha 6 beta 4 integrin: charting the path between laminin binding and nuclear events
J. Cell Sci., January 6, 1996; 109(6): 1165 - 1172.
[PDF]


Home page
ScienceHome page
D. Threadgill, A. Dlugosz, L. Hansen, T Tennenbaum, U Lichti, D Yee, C LaMantia, T Mourton, K Herrup, R. Harris, et al.
Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype
Science, July 14, 1995; 269(5221): 230 - 234.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
B. Symington and W. Carter
Modulation of epidermal differentiation by epiligrin and integrin alpha 3 beta 1
J. Cell Sci., January 2, 1995; 108(2): 831 - 838.
[Abstract] [PDF]


Home page
Genes Dev.Home page
A B Glick, M M Lee, N Darwiche, A B Kulkarni, S Karlsson, and S H Yuspa
Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.
Genes & Dev., October 15, 1994; 8(20): 2429 - 2440.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.